UBS Group’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.84M Sell
90,629
-6,376
-7% -$469K ﹤0.01% 3746
2025
Q4
$6.59M Sell
97,005
-41,537
-30% -$2.59M ﹤0.01% 3740
2025
Q3
$7.9M Buy
138,542
+25,573
+23% +$1.52M ﹤0.01% 3545
2025
Q2
$6.26M Buy
112,969
+1,957
+2% +$91.8K ﹤0.01% 3636
2025
Q1
$4.85M Buy
111,012
+819
+0.7% +$35.7K ﹤0.01% 3812
2024
Q4
$4.74M Buy
110,193
+96,134
+684% +$4.33M ﹤0.01% 3909
2024
Q3
$628K Buy
14,059
+4,563
+48% +$189K ﹤0.01% 5048
2024
Q2
$365K Buy
9,496
+8,016
+542% +$305K ﹤0.01% 5235
2024
Q1
$51K Buy
+1,480
New +$47.5K ﹤0.01% 6497
2023
Q4
Sell
-38,355
Closed -$726K 9395
2023
Q3
$726K Buy
+38,355
New +$728K ﹤0.01% 4366

Other funds holding DBD

UBS Group's DBD Position: Q1 2026 in Review

UBS Group reduced its Diebold Nixdorf (DBD) stake by 6.6% in Q1 2026, selling an estimated $469K and leaving 90,629 shares worth $6.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3746.

UBS Group first reported a position in DBD in Q3 2023 and has held it in 10 quarters since. The position peaked at $7.9M in Q3 2025. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • UBS Group held 90,629 shares of Diebold Nixdorf worth $6.84M as of Q1 2026.
  • UBS Group sold 6,376 Diebold Nixdorf shares in Q1 2026, an estimated $469K.
  • Diebold Nixdorf made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3746 holding.
  • UBS Group first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 10 quarters since.
  • UBS Group's Diebold Nixdorf position peaked at $7.9M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.